Immune-mediated myocarditis in Fabry disease cardiomyopathy causes disease progression and resistance to enzyme replacement therapy. Influence of immunosuppressive therapy
- 4 Anni 2019/2023
- 160.500€ Totale Fondi
Abstract non disponibile
Pubblicazioni Scientifiche
- 2020-06-01 ESC HEART FAILURE
Fabry cardiomyopathy: Gb3-induced auto-reactive panmyocarditis requiring heart transplantation
- 2023-12-01 ESC HEART FAILURE
Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
- 2022-03-01 JOURNAL OF CLINICAL MEDICINE
Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression
- 2022-09-21 JOURNAL OF NEUROSCIENCE
p140Cap Regulates the Composition and Localization of the NMDAR Complex in Synaptic Lipid Rafts
- 2018-09-04 JOURNAL OF THE AMERICAN HEART ASSOCIATION
Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy
- 2021-04-10 ORPHANET JOURNAL OF RARE DISEASES
Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
